Zobrazeno 1 - 10
of 628
pro vyhledávání: '"D. Devore"'
Autor:
Julie M. Steinbrink, MD, MHS, Jennifer Byrns, PharmD, Carl Berg, MD, Matthew Kappus, MD, Lindsay King, MD, MPH, Matthew J. Ellis, MD, Scott Sanoff, MD, MPH, Richa Agarwal, MD, Adam D. DeVore, MD, MHS, John M. Reynolds, MD, Matthew G. Hartwig, MD, MHS, Carmelo Milano, MD, Debra Sudan, MD, Eileen K. Maziarz, MD, Jennifer Saullo, MD, PharmD, Barbara D. Alexander, MD, MHS, Cameron R. Wolfe, MBBS, MPH
Publikováno v:
Transplantation Direct, Vol 9, Iss 11, p e1539 (2023)
Background. Hepatitis C virus (HCV) nucleic acid amplification test (NAAT)–positive donors have increased the organ pool. Direct-acting antivirals (DAAs) have led to high rates of treatment success and sustained virologic response (SVR) in recipien
Externí odkaz:
https://doaj.org/article/1c63abab8b074dfe82c4c9a71e4e91e3
Autor:
Austin Ayer, BS, Benjamin S. Bryner, MD, MS, Chetan B. Patel, MD, Jacob N. Schroder, MD, Carmelo A. Milano, MD, Muath A. Bishawi, MD, PhD, Sarah Casalinova, BS, Adam D. DeVore, MD, MHS
Publikováno v:
JTCVS Open, Vol 14, Iss , Pp 185-187 (2023)
Externí odkaz:
https://doaj.org/article/c055cab51da5449e8b746e5780818f24
Autor:
Josephine Harrington, Jie‐Lena Sun, Gregg C. Fonarow, Stephen B. Heitner, Punag H. Divanji, Gary Binder, Larry A. Allen, Brooke Alhanti, Clyde W. Yancy, Nancy M. Albert, Adam D. DeVore, G. Michael Felker, Stephen J. Greene
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 10 (2023)
Background Many patients with heart failure (HF) have severely reduced ejection fraction but do not meet threshold for consideration of advanced therapies (ie, stage D HF). The clinical profile and health care costs associated with these patients in
Externí odkaz:
https://doaj.org/article/1562516935a04e21a697a6a639dfaab1
Autor:
Adam D. DeVore, Claude Larry Hill, Laine E. Thomas, Nancy M. Albert, Javed Butler, J. Herbert Patterson, Adrian F. Hernandez, Fredonia B. Williams, Xian Shen, John A. Spertus, Gregg C. Fonarow
Publikováno v:
ESC Heart Failure, Vol 9, Iss 1, Pp 178-185 (2022)
Abstract Aims We aimed to develop a risk prediction tool that incorporated both clinical events and worsening health status for patients with heart failure (HF) with reduced ejection fraction (HFrEF). Identifying patients with HFrEF at increased risk
Externí odkaz:
https://doaj.org/article/01086c1b2af64c2caf40b7cb0ad58f19
Autor:
Marc D. Samsky, Renee Leverty, James M. Gray, Alexandra Davis, Brett Fisher, Ashul Govil, Tom Stanis, Adam D. DeVore
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 14, p 4676 (2023)
Use of guideline-directed medical therapy (GDMT) for treatment of heart failure with reduced ejection fraction (HFrEF) remains unacceptably low. The purpose of this study was to determine whether a digital health tool can augment GDMT for patients wi
Externí odkaz:
https://doaj.org/article/5d82be77e5144320bd765d6b6236f8c9
Autor:
Sunit‐Preet Chaudhry, Adam D. DeVore, Himabindu Vidula, Michael Nassif, Karol Mudy, Edo Y. Birati, Timothy Gong, Pavan Atluri, Duc Pham, Benjamin Sun, Aditya Bansal, Samer S. Najjar
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 24 (2022)
Durable implantable left ventricular assist devices (LVADs) have been shown to improve survival and quality of life for patients with stage D heart failure. Even though LVADs remain underused overall, the number of patients with heart failure support
Externí odkaz:
https://doaj.org/article/b815e522031c4f2084d9e3afecbe4ac6
Autor:
Abhinav Sharma, Stephen Greene, Muthiah Vaduganathan, Marat Fudim, Andrew P. Ambrosy, Jie‐Lena Sun, Steven E. McNulty, Adrian F. Hernandez, Barry A. Borlaug, Eric J. Velazquez, Robert J. Mentz, Adam D. DeVore, Brooke Alhanti, Kenneth Margulies, G. Michael Felker
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2608-2616 (2021)
Abstract Aims Associations between growth differentiation factor‐15 (GDF‐15), cardiovascular outcomes, and exercise capacity among patients with a recent hospitalization for heart failure (HHF) and heart failure with reduced ejection fraction (HF
Externí odkaz:
https://doaj.org/article/385af4f80c514fc69c535399a22fde82
Autor:
Merrill Thomas, Yevgeniy Khariton, Gregg C. Fonarow, Suzanne V. Arnold, Larry Hill, Michael E. Nassif, Paul S. Chan, Javed Butler, Laine Thomas, Adam D. DeVore, Adrian F. Hernandez, Nancy M. Albert, J. Herbert Patterson, Fredonia B. Williams, John A. Spertus
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2670-2678 (2021)
Abstract Aims Improving the health status (symptoms, function, and quality of life) of patients with heart failure with reduced ejection fraction (HFrEF) is a primary treatment goal. Angiotensin receptor neprilysin inhibitors (ARNI) improve short‐t
Externí odkaz:
https://doaj.org/article/aebdf592abe7418b8de3475a42c74e82
Autor:
G.Michael Felker, Peter Buttrick, Anthony Rosenzweig, E. Dale Abel, Larry A. Allen, Michael Bristow, Saumya Das, Adam D. DeVore, Stavros G. Drakos, James C. Fang, Jane E. Freedman, Adrian F. Hernandez, Dean Y. Li, Timothy A. McKinsey, Christopher Newton‐Cheh, Joseph G. Rogers, Ravi V. Shah, Svati H. Shah, Josef Stehlik, Craig H. Selzman
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 18 (2022)
Heart failure remains among the most common and morbid health conditions. The Heart Failure Strategically Focused Research Network (HF SFRN) was funded by the American Heart Association to facilitate collaborative, high‐impact research in the field
Externí odkaz:
https://doaj.org/article/fbf3fa3979cc4affabde739b5bcf3cec
Autor:
Brittany Chapman, Anne S. Hellkamp, Laine E. Thomas, Nancy M. Albert, Javed Butler, J. Herbert Patterson, Adrian F. Hernandez, Fredonia B. Williams, Xian Shen, John A. Spertus, Gregg C. Fonarow, Adam D. DeVore
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 12 (2022)
Background There are limited data on the use of angiotensin receptor neprilysin inhibitors (ARNIs) in minority populations with heart failure (HF) with reduced ejection fraction. We used data from the CHAMP‐HF (Change the Management of Patients Wit
Externí odkaz:
https://doaj.org/article/3cb9b1f5e4c6464fa83aedf2ffba96d0